SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$2.87
-0.10 (-3.37%)
▼
5d:
-9.18%
30d:
-36.08%
90d:
-37.34%
HOLD
LOW Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SBC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.29
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$3.29
12.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $2.87, which is considered oversold relative to its 30-day fair value range of $3.05 to $4.02. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.9) compared to its historical average (8.2). Remarkably, the market is currently pricing in an annual earnings decline of 10.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBC is in a strong downtrend. The price is currently testing key support at $2.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.25 (+187.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBC is in a strong downtrend. The price is currently testing key support at $2.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.25 (+187.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.05 -
$4.02
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 187.5% below Wall St target ($8.25)
- CAUTION: Recommendation downgraded due to -9.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.05 -
$4.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.91
Resistance Level
$3.39
Current Trend
Strong Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.92
Wall Street Target
$8.25
(+187.5%)
Revenue Growth (YoY)
-9.0%
Earnings Growth (YoY)
-47.1%
Profit Margin
24.1%
Valuation Discount vs History
-10.4% cheaper
PE vs Historical
5.9 vs 8.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.4%
(market-implied from PE analysis)
1-Year Target
$2.58
(-10%)
2-Year Target
$2.32
(-19%)
3-Year Target
$2.09
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→8)
$2.90
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 7.8%)
$13.42
(+368%)
Base:
(SPY PE: 5.9, Growth: 7.8%)
$3.59
(+25%)
Bear:
(PE: 5.0, Growth: 7.8%)
$3.05
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (6x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 5.94 | Current EPS (TTM): $0.50
Bull Case
$3.17
(+10%)
Analyst growth -3.0%, PE expands to 6.5
Base Case
$2.88
(+0%)
Market implied -3.0%, PE stable at 5.9
Bear Case
$2.02
(-30%)
Severe decline -20.0%, PE contracts to 5.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.9 to 8.2
Stabilization Target:
$3.98
(+38.6%)
PE Expansion Potential:
+38.6%
Share & Embed Analysis
Last updated: May 18, 2026 10:06 PM ET
Data refreshes hourly during market hours. Next update: 11:06 PM
Data refreshes hourly during market hours. Next update: 11:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Yoshiyuki Aikawa
SELL
4422900 shares
2026-03-06
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$228 | 57 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$223 | 53 HOLD |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$206 | 48 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$96 | 55 HOLD |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$105 | 53 HOLD |
